Live Breaking News & Updates on Professor Chad Heatwole

Stay updated with breaking news from Professor chad heatwole. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AMO Pharma Announces MHRA Confirmation of CDM1-RS as Approvable Primary Outcome Measure in Myotonic Dystrophy

/PRNewswire/ AMO Pharma Limited ("AMO Pharma"), a privately held biopharmaceutical company focusing on rare childhood-onset neurogenetic disorders with. ....

United Kingdom , City Of , Kaitlin Gallagher , Peter Ashley , Nicholas Johnson , Ibraheem Mahmood , Pharma Limited , Drug Administration , Toxicology Centre , Regulatory Agency , National Health Service , Development Profile , National Institute For Health , Commission On Human Medicines , University Of Rochester , Myotonic Dystrophy Health Index , Berry Company Public Relations , Scottish Medicines Consortium , United Kingdom Medicines , Professor Chad Heatwole , Professor Nicholas Johnson , Innovation Passport , Innovative Licensing , Access Pathway , National Institute , Care Excellence ,